mRNA vaccine yields modest cut in COVID-19 infection in veterans with cirrhosis

mrna vaccine yields modest cut in covid 19 infection in veterans with cirrhosis

Sumary of mRNA vaccine yields modest cut in COVID-19 infection in veterans with cirrhosis:

  • September 10, 2021 2 min read Source/Disclosures Published by: Disclosures: The authors report no relevant financial disclosures.
  • Back to Healio A cohort of veterans with cirrhosis who received the mRNA COVID-19 vaccine had a delayed and modest decrease in infection, with an excellent decrease in hospitalizations or death.
  • “Patients with cirrhosis have immune dysregulation that is associated with vaccine hyporesponsiveness with several vaccines including hepatitis B and pneumococcal vaccines,” Binu V.
  • John, MD, MPH, affiliate associate professor, University of Miami Miller School of Medicine, chief of hepatology, Bruce W Carter VA Medical Center, and colleagues wrote.
  • “Therefore, the efficacy of the vaccine in patients with cirrhosis, particularly decompensated cirrhosis, is a significant knowledge gap.
  • ” To fill that gap, John and colleagues conducted a retrospective study of 20,037 patients with cirrhosis who received at least one dose of either the Pfizer BNT162b2 mRNA (n = 10, 236) or Moderna mRNA-1273 COVID-19 vaccine (n = 9,801) at the Veterans Health Administration.
  • Investigators matched the patients to 20,037 control participants to evaluate the correlations of vaccination with new COVID-19 infection and COVID-19 hospitalization and death.
  • COVID-19 infection documented by a positive result by polymerase chain reaction, hospitalization and death due to COVID-19 infection served as the primary outcome.

Want to know more click here go to source.

From -


Site Language

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.